Evolva Holding SA

  • WKN: 2121806
  • ISIN: CH0021218067
  • Land: Schweiz

Nachricht vom 08.04.2021 | 19:15

Evolva shareholders approve all proposed resolutions at the Annual General Meeting 2021

Evolva Holding SA / Key word(s): Miscellaneous

08-Apr-2021 / 19:15 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.


Reinach, April 8, 2021 - Evolva shareholders approved all proposals put forward by the Board of Directors at Evolva's Annual General Meeting (AGM). In accordance with the Swiss COVID-19 Ordinance 3, the 2021 AGM was held without shareholders being physically present. Accordingly, shareholders exercised their shareholder rights via the Independent Proxy.  

Increase of the Authorized Capital
Shareholders approved the increase of Authorized Capital in the maximum amount of CHF 2,968,782.35 (respectively maximum of 59,375,647 registered shares) by CHF 4,634,391.20 to the new maximum amount of CHF 7,603,173.55 (respectively maximum of 152,063,471 registered shares).

Elections of the Chairman and of the Board of Directors
Shareholders re-elected Beat In-Albon as Chairman of the Board of Directors as well as Richard Ridinger and Stephan Schindler as members of the Board of Directors, for a one year period.

In addition, Christoph Breucker was elected as new member of the Board of Directors.

Election of the Compensation Committee
Shareholders elected Richard Ridinger, Stephan Schindler and Christoph Breucker as members of the Compensation Committee.

Election of the Auditors
The Shareholders elected Mazars Ltd., Zurich, as auditors for a term of one year.

For a detailed listing of all resolutions at the 2021 Annual General Meeting, please visit: evolva.com/shareholder-info/annual-general-meeting-of-shareholders/.

About Evolva
Evolva is a Swiss biotech company focused on the research, development and commercialization of ingredients based on nature. We have leading businesses in Flavors and Fragrances, Health Ingredients and Health Protection. Evolva's employees, half of which are women, are dedicated to make the best products that can contribute to health, wellbeing and sensory enjoyment. Find out more at evolva.com.

For Evolva multi media content, please visit: evolva.com/multimedia-library/.

Disclaimer
This press release contains specific forward-looking statements, e.g. statements including terms like believe assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicity or implicity presumed in these statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments.

Contact
Barbara Duci
Head of Investor and Corporate Relations
+41 61 485 2003
+41 79 739 2636
barbarad@evolva.com



End of ad hoc announcement

 

show this

GBC im Fokus

Überdurchschnittlich attraktiv: ETP der German Real Estate Capital S.A:

Die German Real Estate Capital S.A. ist die Emittentin eines ETP (Exchange Traded Product) und damit einer börsennotierten Schuldverschreibung. Im Marktvergleich weist dieses ETP ein deutlich überdurchschnittliches Rating/Risikoprofil auf. Es liegt im Rahmen unserer Analyse weit oberhalb der Regressionsgeraden (+34,6 %) und ist damit nach unserer Einschätzung stark überdurchschnittlich attraktiv.

News im Fokus

Symrise erweitert Portfolio an maßgeschneiderten Geschmackslösungen durch Erwerb von Giraffe Foods Inc.

07. Dezember 2021, 08:00

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

ABO Wind AG

Original-Research: ABO Wind AG (von First Berlin Equity Research GmbH): Buy

07. Dezember 2021